Fundamental dimension Equity attribute | ABNBPeer $172.01▼-2.13% Cap $103.0BP/E 38.9x QuantScore59/100 | ACCYYPeer $10.01▼-4.39% Cap $11.83BP/E 38.7x QuantScore59/100 | BKNGLeader $155.83▼-3.27% Cap $117.1BP/E 17.2x QuantScore64/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
85/100 |
49/100 |
48/100 |
Valuation Multiples, PEG & DCF upside | 31/100 | 81/100 | 96/100 |
Health Piotroski, Altman Z, leverage & liquidity | 74/100 | 38/100 | 64/100 |
Growth Revenue / earnings growth & margins | 48/100 | 29/100 | 45/100 |
Sentiment Analyst ratings, targets & revisions | 56/100 | 100/100 | 69/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 38.9x | 38.7x | 17.2x |
Forward P/E (next FY) | 32.4x | 23.0x | 14.9x |
EV / EBITDA (TTM) | 32.7x | 11.3x | 11.2x |
Price / Sales | 7.8x | 1.8x | 4.1x |
Price / Free Cash Flow | 21.2x | 17.0x | 12.3x |
PEG ratio | 7.43 | -0.79 | 0.31 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 8 / 9 | 6 / 9 |
Altman Z-Score | 3.73 (Safe) | 1.86 (Grey) | 5.93 (Safe) |
Total debt / equity | 0.32 | 1.18 | -1.92 |
Quick ratio | 1.4x | 1.3x | 1.1x |
Interest coverage | 74.6x | 5.3x | 8.8x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +10.8% | +0.6% | +13.4% |
Net income growth YoY | -5.2% | -29.3% | -8.1% |
Gross margin (TTM) | 78.0% | 64.4% | 100.0% |
Operating margin (FY) | 21.2% | 15.4% | 34.5% |
FCF margin (FY) | 37.8% | 10.9% | 33.8% |
5. Trailing price performancePrice change over period |
1M return | +9.2% | -3.7% | -1.0% |
3M return | +21.9% | -5.3% | -12.2% |
6M return | +20.4% | -1.0% | -13.5% |
Year to date | +26.7% | -10.7% | -27.3% |
1Y return | +33.3% | -4.5% | -24.3% |
3Y return | +45.2% | +55.7% | +37.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $111.83 -35.0% premium | $15.67 +56.6% upside | $231.69 +48.7% upside |
Wall Street consensus target | $180.91 +5.2% · range $125.00–$220.00 | — — | $229.76 +47.4% · range $188.00–$270.00 |
Consensus stance | 52% Buy39% Hold9% Sell | 100% Buy0% Hold0% Sell | 65% Buy35% Hold-0% Sell |